Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 0.3.

  • Journey Medical's Equity Ratio rose 7819.26% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year increase of 7819.26%. This contributed to the annual value of 0.25 for FY2024, which is 554.97% down from last year.
  • As of Q3 2025, Journey Medical's Equity Ratio stood at 0.3, which was up 7819.26% from 0.24 recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Equity Ratio peaked at 0.43 during Q4 2021, and registered a low of 0.13 during Q3 2021.
  • Over the past 5 years, Journey Medical's median Equity Ratio value was 0.24 (recorded in 2022), while the average stood at 0.21.
  • In the last 5 years, Journey Medical's Equity Ratio crashed by 9997.66% in 2023 and then skyrocketed by 24159487.64% in 2024.
  • Over the past 5 years, Journey Medical's Equity Ratio (Quarter) stood at 0.43 in 2021, then plummeted by 62.63% to 0.16 in 2022, then skyrocketed by 63.98% to 0.26 in 2023, then fell by 5.55% to 0.25 in 2024, then grew by 21.55% to 0.3 in 2025.
  • Its Equity Ratio was 0.3 in Q3 2025, compared to 0.24 in Q2 2025 and 0.25 in Q1 2025.